Supplemental Experimental Procedures. Animals: For in vitro studies, male Wistar rats (180-220 g) were purchased from Harlan Laboratories (IN, USA). For in vivo studies, male Sprague-Dawley rats weighing (250 and 300 g) were obtained from SASCO Breeding Laboratories (Omaha, NE). In all cases, rats were housed in rooms with constant temperature (22-24°C) under 12-12 hour light-dark cycle and given free access to normal chow and water ad libitum. All the procedures used in this study were carried out and approved in agreement with Georgia Regents University and the University of Nebraska Institutional Animal Care and Use Committee guidelines.
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. Rats were anesthetized (isoflurane (4%) and a stereotaxic apparatus was used to pressure inject 350 nL of rhodamine-labeled microspheres (Lumaflor) into the RVLM (starting from bregma, 12 mm caudal along the lamina, 2 mm medial lateral, and 8 mm ventral). In general, RVLM injection sites were centered at Bregma level -11.8 -12.1 mm and ventrally located with respect to the nucleus ambiguous. The location of the tracer was verified histologically 1, 2 . A sample of an RVLM injection is shown in Fig.S1 . Injections located either more rostral or lateral to the targeted area did not result in PVN labeling, and these animals were discarded from the study. Animals were used for electrophysiology 3-5 days after surgery.
Patch clamp electrophysiology:
Whole-cell patch-clamp recordings from retrogradely-labeled PVN neurons were obtained as previously described (3) (4) (5) (6) (7) were pulled from thin-walled (1.5 mm od, 1.17 mm id) borosilicate glass (G150TF-3, Warner Instruments, Sarasota, FL) on a horizontal Flaming/Brown micropipette puller (P-97, Sutter Instruments, Novato, CA). The internal solution contained in mM: 140 potassium gluconate, 5 EGTA, 10 HEPES, 10 KCl, 0.9 MgCl 2 , 0.5 CaCl 2 , 4 MgATP, 0.3 NaGTP, and 20 phosphocreatine (Na + ); pH was adjusted to 7.2-7.3 with KOH, and the osmolality was 285 mOsm. Recordings were obtained with an Axopatch 700A amplifier (Axon Instruments, Foster City, CA) using a combination of fluorescence illumination and infrared differential interference contrast (IR-DIC) videomicroscopy. The voltage output was digitized at 16-bit resolution, 10 kHz and was filtered at 2 kHz (Digidata 1440A, Axon Instruments). Data were discarded if the series resistance was not stable throughout the entire recording (>20% change). For current-clamp recordings, the mean firing rate was analysed in segments of 2 min before, during and after bath-applied drugs. Patched astrocytes were filled with lucyfer yellow and pseudo colored green for display. Astrocyte glutamate transporter currents were recorded in the presence of the ionotropic glutamate receptor blockers: AP5 (100 µM) and DNQX (20 µM) before and after AngII application (0.5 µM, either bathapplied or puffed into the recorded astrocyte).
Microinjections into the PVN. Rats were anesthetized with -chloralose (70-140 mg/kg, i.p) and urethane (0.75-1.5 g/kg, i.p). Rats were placed in a stereotaxic apparatus. An incision was made on the midline of the scalp to expose bregma. The coordinates of the right PVN with reference to bregma were calculated as being, 1.5 mm posterior, 0.4 mm lateral, and 7.8 mm ventral to the dura. 30 mins after the surgery, a needle (0.2 mm OD) that was connected to a microsyringe (0.5 l) was lowered into the PVN and various drugs (50 -100 nl) injected as previously described 3, 4 . At the completion of the experiment, monastral blue dye (2 % Chicago blue, 30 nl) was injected into the brain for histological verification. For GFAP-SOD2 plasmid transfection, a similar procedure was used. In this case, a 200 nl solution of pcDNA3-GFAPp-SOD2 plasmid (kind supplied by Dr. Giffard from Stanford University) mixed with the cationic lipid Lipofectamine 2000 (Invitrogen, Carlsbad, CA) was microinjected into the PVN. The plasmid-lipid complexes were prepared by gently mixing plasmid with the same volume of Lipofectamine 2000 and incubating at room temperature (25 °C) for 45 min. Two days after injection, the rats were used for functional and immunohistological experiments. The transfection efficiency (SOD2 expression) was determined using Western blot. No damage to the neurons within the PVN was observed from light microscopic evaluation.
Renal sympathetic nerve activity and arterial pressure measurements. Rats were anesthetized with -chloralose (70-140 mg/kg, i.p) and urethane (0.75-1.5 g/kg, i.p). The femoral vein was cannulated for administration of supplemental anesthesia and 0.9 % saline. The femoral artery was cannulated for recording mean arterial pressure (MAP) and heart rate (HR). The left renal nerve was isolated and the electrical signal was recorded with the PowerLab (ADInstruments, CO) to monitor RSNA as described before 3, 4 . Basal nerve activity was determined at the beginning of the experiment, and background noise was determined by nerve activity recorded at the end of the experiment (after the rat was euthanized). The nerve activity during the experiment was calculated by subtracting the background noise from the recorded value. The changes in integration and frequency of the nerve discharge were expressed as a percentage from basal value. Responses of MAP and HR were expressed as the absolute difference between the basal value and the value after each dose of a drug.
Western blotting. PVN punches from GFAP-SOD2 plasmid injected and sham-injected rats were lysed in 50 l lysis buffer (10 mM Tris, 1 mM EDTA, 1% SDS, 0.1% Triton X-100 containing complete protease inhibitor cocktail from BaculoGold) for 20 min at 4 C. Samples were homogenized on ice using a sonicator (GraLab 545) for 5-10 s and subjected to electrophoresis. Protein content of lysates was estimated using the bicinchoninic acid method with bovine serum albumin as a standard (Pierce, Rockford, IL). Samples were adjusted to normalize the concentration of total protein using 1% SDS, and then equal volumes of 2 X 4% SDS sample buffer were added. The protein (20-30 g), mixed with SDS-PAGE buffer, was loaded and fractionated on a polyacrylamide gel and subsequently transferred to a polyvinylidene difluoride (PVDF) membrane (Millipore). Non-fat dry milk (5% w/v) in TBST (10 mM Tris, 150 mM NaCl, 0.05% Tween-20) was used to block membrane at ambient temperature for 1h. Then the membrane was incubated with rabbit Anti-Mn-SOD (Millipore) primary antibody overnight at 4°C overnight, followed by the corresponding peroxidase-conjugated secondary antibody for 1h. An enhanced chemiluminescence substrate (Pierce Chemical, Rockford, IL) was used to visualize the signals, which were detected by Worklab digital image system. Image J (NIH) was used to quantify the signal. GAPDH was used as the housekeeping gene.
Hypothalamic Astrocyte Isolation:
Enriched astrocytes were isolated from the hypothalamus using Percoll density gradient as previously described 5 . Briefly, animals were transcardially perfused with sterile saline. The hypothalamus was macro-dissected, mechanically homogenized with Dulbecco's phosphate-buffered saline (dPBS) supplemented with 2% glucose and passed by a 40 µm cell strainer. The resulting homogenate was briefly centrifuged and the cell pellet was re-suspended in 70% isotonic Percoll. A discontinued Percoll density gradient (50, 35 and 0%) was layered over the 70% suspension and centrifuged at 1200 ×g for 55 min. The resulting 50 and 35% interphase containing astrocytes was collected, washed in dPBS and re-pellet by centrifugation at 1000 ×g for 15 min. The resulting pellet was resuspended in 100 µl of dPBS. Cell counting and morphological analysis was performed using a handheld automatic cell counter (Scepter instrument, EMD Millipore, USA). Standard immunofluorescence was performed in order to characterize the population collected. Cells were fixed in PFA 4% for 30 min and immunostained with the astrocyte marker glial fibrillary acidic protein 1:200) and the astrocyte transporter GLT1 (anti-guinea pig, 1:200) in dPBS-Tween 0.05% and 5% horse serum overnight. Hoechst counterstaining (1 g/ml) was performed after the complete immunohistochemistry reaction. To evaluate whether AT1a receptor mRNA was expressed in the collected astrocytes, we performed real time PCR experiments. cDNA was obtained from 50.000 cells/animal using Power SYBR green cells-to-Ct kit according to the manufacture instructions (Ambion, life technologies, USA). PCR amplification of cDNA was also performed using the same kit -4µl of cDNA was added to a PCR cocktail with gene specific primer 
